Background: Celiac disease (CD) is a gluten-triggered autoimmune disorder of the small intestine. A lifelong gluten-free diet (GFD) is the only approved treatment; however, strict adherence is difficult and many suffer from inadvertent gluten exposure. Oral egg yolk anti-gliadin antibody (AGY) is a novel treatment to neutralize gluten and may improve the efficacy of the GFD.
Aims: To determine the safety, tolerability, and potential efficacy of AGY in patients with CD.
Methods: This 6-week, open-label, single-arm study was conducted in adults with biopsy-proven CD on a GFD. Safety measures included adverse events, physical examination, and clinical laboratory tests. Additional measures included a daily Celiac Symptom Index, Health-Related Quality of life, anti-tissue transglutaminase and anti-gliadin IgA/IgG, and lactulose/mannitol excretion ratio (LMER). A 2-week run-in period to assess questionnaire compliance and acceptability of baseline safety laboratory results was followed by a 4-week treatment period with two AGY capsules taken before meals.
Results: Ten patients completed the study (mean age 43.4 years, nine female). All followed a GFD for at least 6 months (mean 5 years). No safety concerns were identified. Most patients had fewer celiac symptoms (especially tiredness, headache, and bloating), improved quality of life, lowered antibodies, and lowered LMER when taking AGY compared to the run-in period.
Conclusion: In our cohort, AGY was safe and potentially associated with improved CD-related outcome measures in patients on a GFD. A larger study powered for further safety and efficacy evaluation is planned.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1007/s10620-016-4426-5 | DOI Listing |
Eur J For Res
May 2024
Department of Renewable Resources, University of Alberta, 442 Earth Science Buildings, Edmonton, AB T6G 2E3 Canada.
Growth and yield (G&Y) of forest plantations can be significantly impacted by maladaptation resulting from climate change, and assisted migration has been proposed to mitigate these impacts by restoring populations to their historic climates. However, genecology models currently used for guiding assisted migration do not account for impacts of climate change on cumulative growth and assume that responses of forest population to climate do not change with age. Using provenance trial data for interior lodgepole pine ( subsp.
View Article and Find Full Text PDFWorld J Diabetes
August 2024
Central Laboratory, Hangzhou First People's Hospital, Hangzhou 310006, Zhejiang Province, China.
We develop a novel method to completely solve the 3-term partial exponential Diophantine equation that represents a generalization of the standard discrete logarithm problem. Our method not only reveals the internal structure of the equation's solution and yields a numerical algorithm to solve it systematically, but also provides an alternative approach to the discrete logarithm problem.
View Article and Find Full Text PDFACS Appl Mater Interfaces
February 2024
CQUM, Centre of Chemistry, University of Minho, Campus de Gualtar, 4710-057 Braga, Portugal.
Two independent artificial neural network (ANN) models were used to determine the optimal drug combination of zeolite-based delivery systems (ZDS) for cancer therapy. The systems were based on the NaY zeolite using silver (Ag) and 5-fluorouracil (5-FU) as antimicrobial and antineoplastic agents. Different ZDS samples were prepared, and their characterization indicates the successful incorporation of both pharmacologically active species without any relevant changes to the zeolite structure.
View Article and Find Full Text PDFJ Neurointerv Surg
October 2024
Department of Neurology, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!